A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in SwedenJ. Andersson, Jonas Bergh, Jan Tennvall et al.|Acta Oncologica|2002Cited by 22
A randomised feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancerSara Margolin, Nils‐Olof Bengtsson, Lena Carlsson et al.|Acta Oncologica|2010Cited by 19
High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancerPer Ljungman, Jonas Bergh, Bo Björkstrand et al.|Bone Marrow Transplantation|1998Cited by 10